Abstract:Aim: To discuss the role of Michigan neuropathy screening instrument (MNSI) in evaluating diabetic peripheral neuropathy, and compare with the results of nerve conduction velocity examination. Methods: Eighty d iabetic patients (38 males and 42 females), including 67 type 2 diabetic patients and 13 type 1 diabetic patients, were selected from the outpatients and inpatients in the Second Affiliated Hospital of Kunming Medical College from February 2003 to May 2004. All the 80 patients were evaluated with MNSI at admission: Appearance of feet: 0 for normal appearance, and 1 for abnormal appearance, the latter included deformed, dry skin, callus, infection; Ankle reflexion: foot flexion as negative (0 point), irresponsivity as positive(1 point), between the above two as doubtful (0.5 point); Vibration perception at great toe: 1 for apallesthesia (patient could not feel fork vibration). When the total score was over 2, the result of MNSI was taken as positive. The nerve conduction velocity was examined with 5-passage electromyograph and evoked instrument. Sensibility of MNSI=number of patients with positive MNSI and at least 2 abnormal nerves through performed nerve conduction/number of patients who at least had 2 abnormal nerves through performed nerve conduction ×100%. Specificity of MNSI= number of patients with negative MNSI/number of patients with normal nerve conduction ×100%. Results: All the 80 patients with diab etic peripheral neuropathy were involved in the analysis of results. 1 Among the indices of MNSI, vibration perception at great toe had the highest abnormal rate (55%, 44/ 80); 11% of the patients (9/80) had abnormal appearance of feet and/or ulceration, and they always had abnormal ankle reflexion or abnormal vibration perception at great toe at the same time. 2 Among the nerve conduction velocity examination, sural nerve and peroneal nerve had the highest abnormal rate, which were 59% (41/80) and 38% (30/80). 3 Of the 80 diabetic patients, the MNSI was positive in 41 cases, including 37 patients had diabetic peripheral neuropathy with the score of MNSI > 2, and 9 patients had diabetic peripheral neuropathy with score of MNSI ≤ 2; The MNSI score was negative in 39 cases, including 9 cases had diabetic peripheral neuropathy and 30 cases were normal. The sensitivity of MNSI for diagnosis of diabetic peripheral neuropathy was 80%, and the specificity was 88%. Conclusion: 1 It is suggested that diabetic periph eral neuropathy is more serious when the abnormal appearance of feet and/or ulceration appears. 2 Nerves of lower limbs have the most probability of being damaged in diabetic patients. 3 MNSI has good sensitivity and specificity in the diagnosis of diabetic peripheral neuropathy, which are 80% and 88% respectively.

A STUDY TO EVALUATE THE PREDICTORS OF DIABETIC PERIPHERAL NEUROPATHY AND UTILITY OF MICHIGHAN NEUROPATHY SCREENING INSTRUMENT AMONG PATIENTS WITH TYPE 2 DIABETES MELLITUS

Prevalence of Peripheral Neuropathy in Patients with Diabetes: A Systematic Review and Meta-Analysis

Precision of Michigan Neuropathy Screening Instrument (MNSI) Tool for the Diagnosis of Diabetic Peripheral Neuropathy Among People with Type 2 Diabetes-A Study from South India.

A Comparison of Clinical Effectiveness of Different Neuropathy Scoring Systems in Screening Asymptomatic Diabetic Peripheral Neuropathy

Screening and Prevalence of Peripheral Neuropathy in Type 2 Diabetic Outpatients: a Randomized Multicentre Survey in 12 City Hospitals of China

Specificity and sensitivity of diabetic peripheral neuropathy screened by Michigan neuropathy screening instrument

The Diagnostic Value of Neuropathy Symptom and Change Score, Neuropathy Impairment Score and Michigan Neuropathy Screening Instrument for Diabetic Peripheral Neuropathy

Using biothesiometer, Neuropathy Symptom Score, and Neuropathy Disability Score for the early detection of peripheral neuropathy: A cross-sectional study

Comparison and study of the different assessments for diabetic peripheral neuropathy

Advances in Screening, Early Diagnosis and Accurate Staging of Diabetic Neuropathy

Scoring Systems to Screen for Diabetic Peripheral Neuropathy

Plantar threshold sensitivity assessment using an automated tool-Clinical assessment comparison between a control population without type 2 diabetes mellitus, and populations with type 2 diabetes mellitus, with and without neuropathy symptoms

Plantar pressure distribution profile of type 2 diabetes mellitus with diabetic foot syndrome: A hospital-based observational study

Promising predictors of diabetic peripheral neuropathy in children and adolescents with type 1 diabetes mellitus

Assessment of Peripheral Neuropathy Using Measurement of the Current Perception Threshold with the Neurometer® in Patients with Type 1 Diabetes Mellitus.

A Machine Learning-Based Severity Prediction Tool for the Michigan Neuropathy Screening Instrument

Ankle Reflex and Neurological Symptom Score: a Primary Level Screening Method for Diabetic Peripheral Neuropathy.

Early Detection of Diabetic Peripheral Neuropathy in Diabetic Patients: A Cross-Sectional Study

Early Detection of Diabetic Peripheral Neuropathy: A Focus on Small Nerve Fibres

A machine learning-based severity prediction tool for diabetic sensorimotor polyneuropathy using Michigan neuropathy screening instrumentations

Prevalence of peripheral neuropathy, amputation, and quality of life in patients with diabetes mellitus